Vaccines; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; Medicines for alleviating constipation; Medicines for intestinal disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97486232

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 79000.048UST

44D Filed

44D Current

44E filed

44E Current

Yes

66A Filed

66A Current

Current Basis

No Basis

Design Code(s)

05.03.08 -

More than one leaf, including scattered leaves, bunches of leaves not attached to branches

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History

Status Date	Action Taken
26^th Nov 2024	NOTICE OF REGISTRATION CONFIRMATION EMAILED
26^th Nov 2024	REGISTERED-PRINCIPAL REGISTER
24^th Sep 2024	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24^th Sep 2024	PUBLISHED FOR OPPOSITION
04^th Sep 2024	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19^th Aug 2024	CASE RETURNED TO EXAMINATION
19^th Aug 2024	NOTICE OF ALLOWANCE CANCELLED
15^th Aug 2024	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15^th Aug 2024	SOU EXTENSION 2 GRANTED
15^th Aug 2024	PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

TRANSTHERA

Classification Information

Class [005]Pharmaceutical Products